Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
A. Achaiah (Oxford, United Kingdom), A. Pereira (Oxford, United Kingdom), H. Bothwell (Oxford, United Kingdom), K. Dwivedi (Oxford, United Kingdom), A. Rathnapala (Oxford, United Kingdom), R. Barker (Oxford, United Kingdom), V. Iotchkova (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom), L. Ho (Oxford, United Kingdom). Blood leukocyte levels as potential prognostic markers in IPF. 388

Member's Comments

No comment yet.

Related content which might interest you: Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry Source: Eur Respir J, 55 (4) 1901855; 10.1183/13993003.01855-2019 Year: 2020 Evaluation of CCL18 serum levels and genetic variant as prognostic biomarkers in SSc-ILD Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Elevation of circulating endothelial cell levels in lung cancer – a new prognostic and/or predictive marker? Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008 Blood eosinophil as a biomarker in COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 The predictive prognostic role of elevated blood d-dimer and blood lactate in severe sepsis patients Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009 Serum markers of IPF Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases Year: 2004 Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Free plasmatic circulating DNA as prognostic and diagnostic lung cancer biomarker Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Circulating adhesion molecules as prognostic markers in childhood asthma Source: Eur Respir J 2004; 24: Suppl. 48, 160s Year: 2004 Serum CC16 is a potential predictor for IPF diagnosis and prognosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Is YKL-40 a prognostic marker in sarcoidosis? Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 alpha-v-beta-6 integrin may be a potential prognostic biomarker in interstitial lung disease Source: Eur Respir J 2015; 46: 486-494 Year: 2015 Circulating total leptin as a diagnostic and prognostic biomarker in sepsis Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Source: Eur Respir J 2016; 47:1299-1303 Year: 2016 Prognostic significance of plasma D-dimer (DD) in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Idiopathic Pulmonary Fibrosis. Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 An elevated neutrophil lymphocyte ratio is a poor prognostic marker in all categories of pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003